Inventor

Biao Xi

Inventor
San Diego, CA, US

Overview

18→
Patents
2012–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes25%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
PatentTitleYear
11,007,197EGFR modulators and uses thereof202110,799,504Heterocyclic compounds and uses as anticancer agents202010,596,174Pyrrolopyrimidine compounds as inhibitors of protein kinases202010,562,918Heterocyclic compounds and uses thereof202010,551,371System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function202010,533,985Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution202010,449,196EGFR modulators and uses thereof201910,012,636Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution20189,920,074'Heterocyclic compounds and uses thereof'20189,763,949'EGFR modulators and uses thereof'20179,709,548'Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution'20179,623,027'EGFR modulators and uses thereof'20179,612,234'Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments'20179,586,965'Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases'20179,464,089'Heterocyclic compounds and uses thereof'20169,034,885'EGFR modulators and uses thereof'20158,685,988'EGFR modulators and uses thereof'20148,252,822'Heterocyclic compounds and uses as anticancer agents'2012

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2012–2020Patents assigned to ACEA BIOSCIENCES INC (16)· patent assignee history
2012–2020Patents assigned to WANG XIAOBO (4)· patent assignee history
2012–2020Patents assigned to XI BIAO (4)· patent assignee history
2012–2020Patents assigned to XU XIAO (4)· patent assignee history
2012–2021Based in San Diego, CA, US· patent location history
2019–2021Patents assigned to ACEA THERAPEUTICS INC (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ACEA BIOSCIENCES INC162012–2020
ACEA THERAPEUTICS INC52019–2021
WANG XIAOBO42012–2020
XI BIAOself42012–2020
XU XIAO42012–2020
Locations
LocationPatentsSpan
San Diego, California, US182012–2021